Vitrafy Life Sciences Partners with Vitalant Innovation Center to Advance Next-Generation Frozen Red Blood Cell Platform as Legacy Technology Reaches End of Life
Vitrafy Life Sciences, Inc., a life sciences company redefining cryopreservation, today announced a partnership with Vitalant Innovation Center for testing services as Vitrafy seeks to advance, approve, and deploy its next-generation cryopreservation ecosystem. The Innovation Center is part of Vitalant, one of the largest nonprofit blood and biotherapies healthcare organizations in the United States. The collaboration addresses a pivotal industry transition: as glycerol-based frozen red blood cell (RBC) technology reaches the expected end of its operational life, the U.S. blood community requires a successor to preserve and build upon decades of established capability.
